February 11, 2019, Endorcine Today
The risk for developing a "more aggressive" form of breast cancer is higher among women with type 2 diabetes compared with women without diabetes, according to findings published in Diabetes Care. Use of insulin analogues did not increase risk for more aggressive breast cancers, according to researchers.
Read more.